Vira Regen Inc.

Vira Regen is pioneering electrogenetics—a new class of bioelectronic medicine that uses precision electrical signals to modulate gene expression and activate the body’s natural regenerative pathways. Our platform is designed to move beyond conventional electrical stimulation by targeting specific genetic and biological pathways involved in tissue repair and regeneration. By combining bioelectric stimulation with computational biology, transcriptomic profiling, and signal discovery, Vira Regen is developing noninvasive therapies that can precisely influence cellular behavior at the site of injury. Our lead program, OsteoVolt™, is a noninvasive bioelectronic bone regeneration technology designed to accelerate healing of fresh and nonunion fractures. Preclinical studies have demonstrated accelerated bone regeneration and fracture healing, and the program is advancing through large-animal validation toward a Class II 510(k) regulatory pathway. Beyond bone regeneration, Vira Regen is building its electrogenetic therapeutic modality as a platform technology for regenerative medicine, with potential applications across musculoskeletal disease, osteoporosis, osteoarthritis, oncology, and healthy longevity. Our vision is to create a new generation of medicines that don't simply treat disease—they use the body's own biological signaling systems to regenerate and restore function.